Jerzy Gumulka serves as Executive at CNS Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Jerzy Gumulka has executed 3 insider transactions totaling $19.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 1, 2024 involved purchasing 33,333 shares valued at $10.0K.
Jerzy Gumulka currently holds 43,006 shares of CNS Pharmaceuticals, Inc. (CNSP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jerzy Gumulka has been a net buyer of CNSP stock. They have purchased $19.6K and sold $0 worth of shares.
Jerzy Gumulka's most recent insider trade was on Feb 1, 2024, when they purchased 33,333 shares at $0.30 per share.
Get notified when new Form 4 filings are submitted
| $1.70 |
| Discretionary |
| Apr 10, 2023 | CNSP | $5.3K | Purchase | 7,173 | $0.74 | Discretionary |